Reach Us +44 1202068036

How to Avoid Covid19 Severe Clinical Evolution?

Paulo Eduardo Ocke Reis1*, Leonardo Roever2, Marcos Cesar Braga Lima3 and Carlos Lenin Jaramillo Cueva4

1Department of Specialized and General Surgery, Fluminense Federal University, Rio de Janeiro, Brazil

2Department of Clinical Research, Federal University of Uberlândia, Brazil

3Especialista em Cardiologia pela Universidade Federal Fluminense, Rio de Janeiro, Brazil

4Especialista em Angiologia e Cirurgia Vascular, Universidad Central del Ecuador, Quito, Ecuador

*Corresponding Author:
Paulo Eduardo Ocke Reis
Department of Specialized and General Surgery
Fluminense Federal University, Rio de Janeiro, Brazil
Tell: +55 21 2629-5000
E-mail: [email protected]

Received Date: June 16, 2020; Accepted Date: June 24, 2020; Published Date: July 01, 2020

Citation: Ocke Reis PE, Leonardo R, Marcos Cesar BL, Carlos Lenin JC (2020) How to Avoid Covid19 Severe Clinical Evolution? J Vasc Endovasc Ther. Vol. 5 No. 3: 14.

Visit for more related articles at Journal of Vascular and Endovascular Therapy

COVID-19 infection was first described associated with respiratory syndrome and elevated mortality worldwide of a specific group of patients, understanding the cause of coronavirus severe illness complications, remains the cornerstone of efforts to provide better approach and appropriated reduce mortality rate [1]. We proposed a change in the CHADS-VASC score (Table 1) [2], including one point for Covid-19 at the score, and, thus, indicating the necessity of prophylaxis with anticoagulant therapy [2]. Patients who respond Covid-19 infection with severe clinical evolution has the same comorbidities of CHADS-VASC. It has been shone the pulmonary impairment due to thrombosis [2,3]. Now we propose an algorithm to demonstrate the flow chart that must follow each group of patient’s suspected or carriers of Covid 19, to reduce in hospital mortality (Figure 1).


Figure 1: Algorithm of anticoagulation, in patients with strong suspicion or positive Covid [2-8].

Table 1 Classic CHA2DS2-VASC. Adding one point CHA2DS2-VASC-C 19.2 TIA- Transient Ischemic Attack.

C Heart Failure 1
H Hypertension 1
A2 Age (≥75) 2
D Diabetes Mellitus 1
S2  History of stroke (TIA) 2
V Peripheral Vascular Disease 1
A Age (65-74) 1
C Suspected or carriers of Covid-19 1

So in this scenario, seeing beyond, with the modified Score CHADS-VASC-C19 2 and algorithm for prophylaxis of Covid-19 pulmonary vascular thrombosis, step by step, we follow-up each group of patient’s suspected or carriers of Covid 19 [2-8] (Figure 1).


Select your language of interest to view the total content in your interested language

Viewing options

Recommended Conferences
Post your comment

Share This Article

Flyer image